Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease.
about
Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategyPharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogsDiscovery and canine preclinical assessment of a nontoxic procaspase-3-activating compoundExpression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cellsCompound K, a metabolite of ginseng saponin, induces mitochondria-dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cellsDifferential effects of procaspase-3 activating compounds in the induction of cancer cell death.Targeting procaspase-3 with WF-208, a novel PAC-1 derivative, causes selective cancer cell apoptosisExpression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer.Synthesis and biological evaluation of benzothiazole derivatives bearing the ortho-hydroxy-N-acylhydrazone moiety as potent antitumor agents.A novel small-molecule activator of procaspase-3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts.Astilbotriterpenic acid induces growth arrest and apoptosis in HeLa cells through mitochondria-related pathways and reactive oxygen species (ROS) production.Neuroprotective effect by Dammishimgyu-herbal acupuncture against H(2)O(2)-induced apoptosis in human neuroblastoma, SH-SY5Y cells.3 Beta-hydroxyolean-12-en-27-oic acid: a cytotoxic, apoptosis-inducing natural drug against COLO-205 cancer cells.Pinelliae Rhizoma herbal-acupuncture solution induced apoptosis in human cervical cancer cells, SNU-17.Anticancer effects of oligomeric proanthocyanidins on human colorectal cancer cell line, SNU-C4.Coptis japonica root extract induces apoptosis through caspase3 activation in SNU-668 human gastric cancer cells.Coptidis rhizoma induces apoptosis in human colorectal cancer cells SNU-C4.Overexpression of caspase-3 in hepatocellular carcinomas.Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205).Induction of apoptosis in HeLa cells by 3beta-hydroxyurs-12-en-27-oic acid.Ginsenoside Rd from Panax notoginseng is cytotoxic towards HeLa cancer cells and induces apoptosis.Protein phosphatase 1-dependent dephosphorylation of Akt is the prime signaling event in sphingosine-induced apoptosis in Jurkat cells.
P2860
Q28260415-AC78D55C-1C54-4780-8521-63994376C5D6Q28283281-C2A52634-CE20-44C6-A9A0-5DF118A44CDBQ28292596-50213104-F15D-4CBC-BCCA-FE4E3B4B7724Q34455521-04531590-85BF-447F-8279-D8B8B6EEE8F9Q35002191-6736EBE9-E0AF-4282-862C-22604F827178Q35946431-727B5164-5984-4467-BFD3-C4AE90AC0FBFQ35995093-E9E0A038-DA69-43C7-98E1-3B0E852C4171Q36190611-A693FC4D-5C65-4708-88BA-AD99E673D334Q38955703-D47C7CAD-DCAB-42DE-8A25-D20CC67578F9Q38972543-FF7ACE3C-51C1-4111-AE52-C25C4C23F307Q39880865-C89941B2-D5E8-4952-843A-0B6AFEA9FB23Q40159330-D877DFB5-EDC2-429F-9A9A-E2BC8668D489Q40189433-78A5F388-7EA6-4D77-A9BF-251E24CC132EQ40277950-BB6680AD-039E-43A2-B2CA-67199AD67321Q40386378-B3F8E599-DC45-4FE0-B7E0-AEDB2AADF176Q40413905-ACC70E79-5B97-4760-A60E-495624875614Q40465072-7A6C64DF-12CF-4CC9-AC9E-EA889323B63CQ40564617-D8F4B735-FBD0-4E55-8763-3BCB27144CACQ45955438-D68E812E-6482-4BE8-8E43-A78AF1728AA0Q51801035-0074142D-2CAC-4812-94D0-3DF356C6CC9BQ53580700-C13DF93F-7DDD-432A-A05C-E927D696E1F3Q54614020-CA68D6E1-DF60-4EF9-A3A5-3AC58BA9F679
P2860
Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Characterization of the interl ...... redominance Hodgkin's disease.
@en
Characterization of the interl ...... redominance Hodgkin's disease.
@nl
type
label
Characterization of the interl ...... redominance Hodgkin's disease.
@en
Characterization of the interl ...... redominance Hodgkin's disease.
@nl
prefLabel
Characterization of the interl ...... redominance Hodgkin's disease.
@en
Characterization of the interl ...... redominance Hodgkin's disease.
@nl
P2093
P2860
P1476
Characterization of the interl ...... redominance Hodgkin's disease.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65398-9
P407
P577
1999-05-01T00:00:00Z